Short-term follow-up is a reasonable alternative to invasive biopsy of palpable (capable of being touched or felt) breast lesions with benign imaging features, particularly in younger women with probable fibroadenoma (non-cancerous tumors that often occur in women during their reproductive years), according to a study published in the December issue of the American Journal of Roentgenology.
The study, performed at the University of Virginia in Charlottesville, Va., consisted of a group of 320 women with 375 palpable masses with benign features for which short-term follow-up was recommended. "We found that only one case of cancer was diagnosed for which short-term follow-up had been recommended," said Jennifer A. Harvey, M.D., lead author of the study.
"Our study of palpable breast lesions with benign features showed an acceptably low prevalence of breast cancer ─ so low that short-term follow-up is a reasonable alternative to biopsy," said Harvey.
"Application of the results of our study may reduce the number of biopsies that result in benign findings. There is also significant cost savings associated with using short-term follow-up rather than immediate biopsy," she said.
This study appears in the December issue of the American Journal of Roentgenology. For a copy of the full study, please contact Heather Curry via email at firstname.lastname@example.org or at 703-390-9822.
The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Röentgen, who discovered the x-ray in 1895.